Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.33 USD | +2.65% | +3.21% | -1.16% |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 33.76 and 29.26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.16% | 693M | C | ||
+4.62% | 55.76B | A- | ||
-11.72% | 17.72B | A- | ||
-5.05% | 13.23B | A | ||
+1.40% | 7.68B | B | ||
-17.93% | 5.39B | B- | ||
+8.62% | 3.28B | C- | ||
-2.31% | 3.23B | C+ | ||
-4.16% | 3.06B | B+ | ||
+12.61% | 2.73B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHCT Stock
- Ratings Community Healthcare Trust Incorporated